Related Experiment Video
Updated: Jul 9, 2025

11:21
Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography
Published on: January 15, 2013
11.6K
Multi-camera optical tracking and fringe pattern analysis for eye surface profilometry in ocular proton therapy.
Riccardo Via1, Katarina Bryjova1, Alessia Pica1
1Center for Proton Therapy, Paul Scherrer Institute, CH-5232 Villigen, Switzerland.
Physics and Imaging in Radiation Oncology
|November 29, 2023
Summary
A new optical tracking system provides high-precision, sub-millimetric 3D eye topography for ocular proton therapy. This system ensures accurate image guidance for treating intraocular tumors.
Area of Science:
- Ophthalmology
- Medical Physics
- Biomedical Engineering
Background:
- Intraocular tumor treatment with proton therapy requires precise eye tracking.
- Current methods may lack the necessary accuracy for optimal radiation delivery.
Purpose of the Study:
- To design and validate an optical tracking system for high-precision eye position and orientation measurement.
- To enable accurate three-dimensional (3D) topography of the anterior eye segment during proton irradiation.
Main Methods:
- Developed a system using four optical cameras and two projectors.
- Employed Fourier Transform Method (FTM) with fringe pattern analysis for 3D topography.
- Integrated stereo triangulation and FTM for phase-to-physical coordinate mapping.
- Validated the system pre-clinically and on patients undergoing proton therapy, comparing results with MRI.
Main Results:
- Achieved sub-millimetric accuracy (median: 0.58 mm) and precision (RMSE: 0.61 mm) in pre-clinical tests.
- Demonstrated a median discrepancy of 0.43 mm (IQR: 0.65 mm) between MRI and FTM-based reconstructions.
- Confirmed the system's capability for reliable eye surface topography acquisition.
Conclusions:
- The developed optical tracking system meets precision and accuracy requirements for image-guided ocular proton therapy.
- The system is ready for clinical testing to evaluate its performance against current standards.
- This technology is expected to enhance the safety and efficacy of proton therapy for intraocular tumors.

